TG Therapeutics, Inc.
New York, New York
Trademarks
BRIUMVI
No. 804230 · Class 5
UBLYXI
International registration 1541707 · Class 5
Holder of 2 trademarks, 1 in force.
From Swissreg, the register of the Federal Institute of Intellectual Property. The register names a holder by name and address only, so a mark is listed here when its holder’s name is this entity’s.
Patents
KOMBINATION VON ANTI-CD20-ANTIKÖRPERN UND PI3-KINASESELEKTIVEM INHIBITOR
EP2914343
KOMBINATION VON ANTI-CD20-ANTIKÖRPERN UND PI3-KINASESELEKTIVEM INHIBITOR
EP3150256
Holder of 2 patents, 0 in force.
From Swissreg, the register of the Federal Institute of Intellectual Property: Swiss patents and European patents with effect in Switzerland. A patent is listed here when its holder’s name is this entity’s.